Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1986-08-26
1989-01-03
Rollins, John W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514935, A61K 3170, A61K 3900
Patent
active
047957441
ABSTRACT:
The use of mismatched dsRNA, e.g. Ampligen for the manufacture of compositions for use in the selective activation of a latent natural defense system within human cells, both cells already infected with AIDS virus as well as cells at risk to infection. Specific treatments for various clinical phases of the biological continuous of AIDS virus-related events ranging from subtle, early immunological lesions to advanced disease are described. Prophylaxis or prevention of AIDS virus related events, such as by introduction of mismatched double-stranded RNA into various blood products or biological fluids to be used in man (e.g., blood transfusion) or around man (e.g., dialysis programs) are also described.
REFERENCES:
patent: 3931397 (1975-01-01), Harnden
patent: 4130641 (1978-12-01), Tso
patent: 4283393 (1981-08-01), Field et al.
patent: 4400375 (1983-08-01), Douthart et al.
patent: 4605394 (1986-08-01), Skarkovich
patent: 4724232 (1988-02-01), Rideout et al.
Journal Of The American Medical Association, vol. 250, No. 9, pp. 1143-1154, (Sep. 4, 1987).
The New England Journal of Medicine, vol. 314, No. 2, pp. 131-132, (Jan. 9, 1986).
J. Infect. Dis., DeStefano et al, vol. 146, pp. 451-455, (Oct. 1982).
Lancet, Aug. 6, 1983, p. 334, Buimovici-Klein.
Travers (1984), Nature 311:410.
Zamennick et al, (1978), PNAS 75: 280-284.
Izant et al, (1984), Cell, vol. 36, pp. 1007-1016.
Stephenson et al, (1978), PNAS 75: 285-288.
May, 1984, Press Release.
Ampligen Research program fact sheet, May 1984.
SCRIP World Pharmaceutical News, Jul. 30, 1984.
SCRIP World Pharmaceutical News, Jun. 3, 1985.
Hahnemann University, "ALUMNI" Magazine, Fall 1984.
"The Pink Sheet", vol. 46, No. 21, pp. T&G-32, 4, May 21, 1984.
UPI report of May 16, 1984.
UPI wire service news reports under various by-lines, May 15 and 16, 1984.
Longo et al, Ann. NY Acd. Sci., 437:421-430.
Spiegel, Serminars in Oncology, 14:1, 1987.
Krigel et al, 1985, Journal of Biological Response Modifiers, 4:358-364.
Friedland et al, Monograph TH.4.6 of Jun. 4, 1987, 3rd International Conference on Acquired Immunodificiency Syndrome (AIDS).
New England J. Medicine, vol. 309, No. 10, pp. 583-586, Sep. 8, 1983.
AIDS Research, Buimovici-Klein et al, vol. 2, No. 2, 1986, pp. 99-108.
Business Wire, Jun. 10, 1987.
Business Wire, Jun. 4, 1987.
Washington Post, Mar. 1, 1988.
HEM Research, Inc.
Rollins John W.
LandOfFree
Modulation of AIDS virus-related events by double-stranded RNAS does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modulation of AIDS virus-related events by double-stranded RNAS, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulation of AIDS virus-related events by double-stranded RNAS will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2168609